Drug Delivery Partnership Strategies

This report builds on interviews with industry executives, case studies, and analysis of deal and other market data to set out a set of strategies to optimally partner for enhanced drug delivery products.

No single drug delivery partnership model can be applied across all drug delivery partnerships. Partnering around drug delivery technology can occur at different stages of the drug development and commercialization lifecycle, requiring varying levels of collaboration and involving multiple different partners and their respective interests.

The degree of intended collaboration between drug delivery technology partners has declined over the past five years. Big pharma has become an increasingly important source for high value licensing investment in novel drug delivery technologies.

Read more...

Comments

Add New Search RSS

Write comment
Name:
Email:	do not notifynotify
Website:
Title:
	Please input the anti-spam code that you can read in the image.

Powered by !JoomlaComment 3.26

3.26 Copyright (C) 2008 Compojoom.com / Copyright (C) 2007 Alain Georgette / Copyright (C) 2006 Frantisek Hliva. All rights reserved."

• Chemical Sales & Marketing Toolbox (30/04/2013)
• Project and Portfolio Managemnet (28/04/2013)
• Real World Data 2013 (04/03/2013)

• CMO Market (17/09/2012)
• Top 20 Oncology Therapy Brands 2011-21 (17/09/2012)
• Orphan Drug (17/09/2012)

• Global CT Market (18/06/2012)
• Innovations in Molecular Diagnostics (18/06/2012)
• Biomarkers in Alzheimer's Disease (18/06/2012)
• Global Generics (16/11/2011)
• Generics in Japan (16/11/2011)
• Global Health Care Equipment (16/11/2011)
• OTC (25/07/2011)
• mHealth and Telemedicine (06/07/2011)
• Epilepsy (01/07/2011)

---